as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹149.35
Change
-0.86 (-0.57%)
Open
₹151.0
Prev. Close
₹150.21
Day High
₹154.9
Day Low
₹148.5
Volume Analysis
Traded
9,940
Delivered
5,508
Delivery %
55.41%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Low return on equity (5.47%)
Opportunities (1)
- •Strong 3-year revenue growth (23.9%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹159.74 | ₹157.32 | ₹153.34 | ₹150.92 | ₹146.94 | ₹144.52 | ₹140.54 |
| Fibonacci | ₹157.32 | ₹154.88 | ₹153.36 | ₹150.92 | ₹148.48 | ₹146.96 | ₹144.52 |
| Camarilla | ₹151.11 | ₹150.52 | ₹149.94 | ₹150.92 | ₹148.76 | ₹148.18 | ₹147.59 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-4.44%
1 Week
-1.61%
1 Month
-5.05%
3 Months
-9.36%
6 Months
+8.65%
1 Year
-10.22%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹420.1
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
5.25%
Net margin 7.96% × asset turnover 0.41x × equity multiplier 1.61x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹284 Cr
P/E (TTM)
8.38
ROE
5.47%
Book Value
₹358.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Nath Bio-genes (i) Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 55/100. The strongest factor is Financial Strength (100/100), while Cash Flow (7/100) is the weakest area to weigh before deciding. Notably: Low return on equity (5.47%). Strong 3-year revenue growth (23.9%).
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Stock is trading at 0.42 times its book value
- +Debtor days have improved from 110 to 70.0 days.
- −Tax rate seems low
- −Company has a low return on equity of 5.93% over last 3 years.
- −Contingent liabilities of Rs.89.3 Cr.
- −Earnings include an other income of Rs.15.2 Cr.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
AGM on 24 September 2026; record date/cut-off for voting is 11 September 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 235 | 23 | 32 | 43 | 244 | 32 | 37 | 52 | 284 | 44 | 66 | 52 | 328 |
| Expenses + | 198 | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 254 | 38 | 62 | 47 | 293 |
| Operating Profit | 37 | 5 | 6 | 4 | 37 | 5 | 8 | 0 | 29 | 6 | 4 | 4 | 35 |
| OPM % | 16.0% | 22.0% | 18.0% | 9.0% | 15.0% | 15.0% | 22.0% | 0.8% | 10.0% | 14.0% | 5.0% | 9.0% | 11.0% |
| Other Income + | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 3 |
| Interest | 3 | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 | 5 | 5 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 34 | 2 | 5 | 3 | 34 | 1 | 4 | 2 | 29 | 5 | 2 | 2 | 33 |
| Tax % | 1.0% | 19.0% | 17.0% | 19.0% | 1.0% | -3.0% | 30.0% | 30.0% | 2.0% | 12.0% | 35.0% | 100.0% | 2.0% |
| Net Profit + | 33 | 2 | 4 | 3 | 33 | 1 | 3 | 1 | 28 | 5 | 2 | 0 | 32 |
| EPS in Rs | 18 | 1 | 2 | 1 | 18 | 1 | 1 | 1 | 15 | 3 | 1 | 0 | 17 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 97 | 109 | 230 | 234 | 248 | 268 | 445 | 490 |
| Expenses + | 82 | 89 | 193 | 185 | 198 | 217 | 393 | 440 |
| Operating Profit | 15 | 20 | 37 | 49 | 50 | 51 | 52 | 49 |
| OPM % | 15.0% | 18.0% | 16.0% | 21.0% | 20.0% | 19.0% | 12.0% | 10.0% |
| Other Income + | 1 | 1 | -87 | 1 | 4 | 4 | 14 | 15 |
| Interest | 2 | 4 | 11 | 10 | 9 | 11 | 16 | 17 |
| Depreciation | 5 | 5 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 9 | 12 | -63 | 36 | 42 | 41 | 46 | 43 |
| Tax % | -1.0% | 4.0% | 6.0% | 3.0% | 5.0% | 5.0% | 10.0% | — |
| Net Profit + | 9 | 12 | -67 | 35 | 40 | 39 | 42 | 39 |
| EPS in Rs | 6 | 7 | -35 | 18 | 21 | 20 | 22 | 20 |
| Dividend Payout % | 0.0% | 0.0% | -6.0% | 11.0% | 10.0% | 10.0% | 9.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Reserves | 30 | 41 | 523 | 554 | 591 | 625 | 661 |
| Borrowings + | 11 | 19 | 93 | 105 | 110 | 123 | 138 |
| Other Liabilities + | 63 | 82 | 105 | 114 | 160 | 259 | 278 |
| Total Liabilities | 120 | 158 | 739 | 793 | 880 | 1,026 | 1,097 |
| Fixed Assets + | 21 | 38 | 245 | 244 | 249 | 250 | 249 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 5 | 5 | 6 | 6 | 6 |
| Other Assets + | 99 | 121 | 490 | 543 | 625 | 770 | 842 |
| Total Assets | 120 | 158 | 739 | 793 | 880 | 1,026 | 1,097 |
| Equity Capital | 16 | 16 | 19 | 19 | 19 | 19 | 19 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | — | — | 17 | 38 | 75 | 18 | -13 |
| Cash from Investing Activity + | — | — | -20 | -3 | -27 | -4 | 3 |
| Cash from Financing Activity + | — | — | -22 | -2 | -8 | -2 | -4 |
| Net Cash Flow | — | — | -25 | 34 | 39 | 11 | -13 |
| CFO/OP | — | — | 54 | 80 | 150 | 37 | -22 |
| Free Cash Flow | — | — | 16 | 36 | 48 | 10 | -16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 49.81% | 49.72% | 49.76% | 49.8% | 49.83% | 49.83% | 50.24% | 51.73% | 53.31% | 54.08% | 54.17% | 54.13% |
| Promoters | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% |
| FII | 0.22% | 0.32% | 0.27% | 0.21% | 0.18% | 0.19% | 0.21% | 0.41% | 0.32% | 0.31% | 0.22% | 0.26% |
| DII | 4.37% | 4.37% | 4.37% | 4.37% | 4.37% | 4.37% | 3.94% | 2.25% | 0.76% | 0.01% | 0.01% | 0.01% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Nath Bio-genes (i) Ltd (this stock) | 284 | 8.38 | 0.42 | 5.47% |
| Annapurna Swadisht Ltd | 285 | 8.42 | 0.87 | 9.71% |
| Megastar Foods Limited | 286 | 28.9 | 2.79 | 9.47% |
| K M Sugar Mills Ltd | 299 | 6.22 | 0.77 | 13.8% |
| Sayaji Industries Ltd. | 308 | 24.8 | 3.32 | 1.49% |
| Coastal Corporation Ltd | 259 | 8.04 | 0.91 | 9.77% |
| The P K Tea Prod Co Ltd | 310 | 369.0 | 1.62 | 0.45% |
Which Mutual Funds Hold Nath Bio-genes (i) Ltd?
Frequently Asked Questions about Nath Bio-genes (i) Ltd
Nath Bio-genes (i) Ltd (NATHBIOGEN) closed at ₹149.35 on NSE on 25 September 2026, down 0.86 (0.57%) from the previous close.
Nath Bio-genes (i) Ltd trades on the NSE (National Stock Exchange of India) under the symbol NATHBIOGEN.
Nath Bio-genes (i) Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 8.38.
Nath Bio-genes (i) Ltd has a dividend yield of 1.34%.
Nath Bio-genes (i) Ltd's 52-week high is ₹207.0 and its 52-week low is ₹126.0.
Nath Bio-genes (i) Ltd has a market capitalisation of ₹284 crore.
Nath Bio-genes (i) Ltd has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Nath Bio-genes (i) Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.